Document ID: chunk:federal_register_of_legislation:F2024L00483:reg:9:p2
Version: federal_register_of_legislation:F2024L00483
Segment Type: reg
Provision Reference: reg 9 (pt 2/2)
Character Range: 8349–10042

ChAdOx1 nCoV-19 vaccine within the 2 months before the clinical onset or clinical worsening;
(9)          experiencing a category 1A stressor within the 30 days before clinical worsening;
Note: category 1A stressor is defined in the Schedule 1 – Dictionary.
(10)      experiencing a category 1B stressor within the 30 days before clinical worsening;
Note: category 1B stressor is defined in the Schedule 1 – Dictionary.
(11)      experiencing a category 2 stressor within the 1 year before clinical onset;
Note 1: A category 2 stressor can arise in a variety of circumstances connected with service. Such circumstances can arise during the course of service, as a result of separation from service and the conditions associated with that separation, and in the transition to civilian life in the years following separation.
Note 2: category 2 stressor is defined in the Schedule 1 - Dictionary.
(12)      having depressive disorder or anxiety disorder, sufficient to warrant ongoing management which may involve regular visits (for example, at least monthly) to a psychiatrist, counsellor or general practitioner, within the 6 months before clinical worsening;
Note: To warrant ongoing management does not require that any actual management was provided.
(13)      undertaking physical activity of five METs or more for a period of at least 6 hours within the 7 days before clinical worsening;
Note: MET is defined in the Schedule 1 – Dictionary.
(14)      being exposed to an environment of extreme heat for a period of at least 6 hours within the 7 days before clinical worsening;
(15)      inability to obtain appropriate clinical management for myasthenia gravis before clinical worsening.